ad
This Article
Right arrow Images Only
Right arrow Full Version
Right arrow PDF Español
Right arrow Additional Image
Services
Right arrow E-mail this link to a friend
Right arrow Related text in Red Book
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow Articles in Pediatrics
Right arrow reprints & permissions
Right arrow Section 1
Section 2
Section 3
Section 4
Section 5
Appendices

The following text is from an archived Red Book® edition and may not reflect current recommendations or information. To view the current edition, click here.

Section 3. Summaries of Infectious Diseases

Tetanus

(Lockjaw)

Clinical Manifestations
Etiology
Epidemiology
Diagnostic Tests
Treatment
Isolation of the Hospitalized Patient
Control Measures

Top
 Next
CLINICAL MANIFESTATIONS: Generalized tetanus (lockjaw) is a neurologic disease that manifests as trismus and severe muscular spasms. Tetanus is caused by neurotoxin produced by the anaerobic bacterium Clostridium tetani in a contaminated wound. Onset is gradual, occurring over 1 to 7 days, and symptoms progress to severe generalized muscle spasms, which often are aggravated by any external stimulus. Severe spasms persist for 1 week or more and subside in a period of weeks in people who recover.

Localized tetanus manifests as local muscle spasms in areas contiguous to a wound. Cephalic tetanus is a dysfunction of cranial nerves associated with infected wounds on the head and neck. Both conditions may precede generalized tetanus.


Top
 Previous
Next
ETIOLOGY: Clostridium tetani, the tetanus bacillus, is a spore-forming, anaerobic, gram-positive bacillus. This organism is a wound contaminant that causes neither tissue destruction nor an inflammatory response. The vegetative form of C tetani produces a potent plasmid-encoded exotoxin (tetanospasmin), which binds to gangliosides at the myoneural junction of skeletal muscle and on neuronal membranes in the spinal cord, blocking inhibitory pulses to motor neurons. The action of tetanus toxin on the brain and sympathetic nervous system is less well documented.


Top
 Previous
Next
EPIDEMIOLOGY: Tetanus occurs worldwide and is more common in warmer climates and during warmer months, in part because of the higher frequency of contaminated wounds associated with those locations and seasons. The organism, a normal inhabitant of soil and animal and human intestines, is ubiquitous in the environment, especially where contamination by excreta is common. Wounds, recognized or unrecognized, are the sites at which the organism multiplies and elaborates toxin. Contaminated wounds, especially those with devitalized tissue and . . . [Go to Full Text]


Related text in Red Book:

Summary of Major Changes in the 2003 Red Book

Red Book 2003: xxv. [Extract] [Full Version]  

Vaccine Safety and Contraindications

Red Book 2003: 37-49. [Extract] [Full Version]  

Scheduling Immunizations

Red Book 2003: 21-23. [Extract] [Full Version]  

Simultaneous Administration of Multiple Vaccines

Red Book 2003: 33. [Extract] [Full Version]  

Antibodies of Animal Origin (Animal Antisera)

Red Book 2003: 60-63. [Extract] [Full Version]  

Active Immunization After Exposure to Disease

Red Book 2003: 83-84. [Extract] [Full Version]  

Injuries From Discarded Needles in the Community

Red Book 2003: 180-182. [Extract] [Full Version]  

Bite Wounds

Red Book 2003: 182-186. [Extract] [Full Version]  

Diphtheria

Red Book 2003: 263-266. [Extract] [Full Version]  

Human Immunodeficiency Virus Infection

Red Book 2003: 360-382. [Extract] [Full Version]  

Pertussis

Red Book 2003: 472-486. [Extract] [Full Version]  



This topic has been referenced by these articles:

  • Abbott;, M., Gerber, M. A., Halsey, N. A., Abramson, J. S. (2001). Varicella Vaccine Question. Pediatrics 107: 612-612 [Full Version]  
  • Strine, T. W., Barker, L. E., Mokdad, A. H., Luman, E. T., Sutter, R. W., Chu, S. Y. (2002). Vaccination Coverage of Foreign-Born Children 19 to 35 Months of Age: Findings From the National Immunization Survey, 1999-2000. Pediatrics 110: e15-15 [Abstract] [Full Version]  
  • Ghaffari, G., Passalacqua, D. J., Caicedo, J. L., Goodenow, M. M., Sleasman, J. W. (2004). Two-Year Clinical and Immune Outcomes in Human Immunodeficiency Virus-Infected Children Who Reconstitute CD4 T Cells Without Control of Viral Replication After Combination Antiretroviral Therapy. Pediatrics 114: e604-e611 [Abstract] [Full Version]  
  • Cherry, J. D. (2003). The Science and Fiction of the "Resurgence" of Pertussis. Pediatrics 112: 405-406 [Full Version]  
  • Cherry, J. D. (2005). The Epidemiology of Pertussis: A Comparison of the Epidemiology of the Disease Pertussis With the Epidemiology of Bordetella pertussis Infection. Pediatrics 115: 1422-1427 [Abstract] [Full Version]  
  • Salmaso, S., Mastrantonio, P., Tozzi, A. E., Stefanelli, P., Anemona, A., Atti, M. L. C. d., Giammanco, A., the Stage III Working Group, (2001). Sustained Efficacy During the First 6 Years of Life of 3-Component Acellular Pertussis Vaccines Administered in Infancy: The Italian Experience. Pediatrics 108: e81-81 [Abstract] [Full Version]  
  • Kirmani, K. I., Lofthus, G., Pichichero, M. E., Voloshen, T., D'Angio, C. T. (2002). Seven-Year Follow-up of Vaccine Response in Extremely Premature Infants. Pediatrics 109: 498-504 [Abstract] [Full Version]  
  • Pichichero, M. E., Edwards, K. M., Anderson, E. L., Rennels, M. B., Englund, J. A., Yerg, D. E., Blackwelder, W. C., Jansen, D. L., Meade, B. D. (2000). Safety and Immunogenicity of Six Acellular Pertussis Vaccines and One Whole-Cell Pertussis Vaccine Given as a Fifth Dose in Four- to Six-Year-Old Children. Pediatrics 105: e11-e11 [Abstract] [Full Version]  
  • Melvin, A. J., Mohan, K. M. (2003). Response to Immunization With Measles, Tetanus, and Haemophilus influenzae Type b Vaccines in Children Who Have Human Immunodeficiency Virus Type 1 Infection and Are Treated With Highly Active Antiretroviral Therapy. Pediatrics 111: e641-644 [Abstract] [Full Version]  
  • Omenaca, F., Garcia-Sicilia, J., Garcia-Corbeira, P., Boceta, R., Romero, A., Lopez, G., Dal-Re, R. (2005). Response of Preterm Newborns to Immunization With a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B Virus-Inactivated Polio and Haemophilus influenzae Type b Vaccine: First Experiences and Solutions to a Serious and Sensitive Issue. Pediatrics 116: 1292-1298 [Abstract] [Full Version]  
  • Committee on Infectious Diseases, (2004). Recommended Childhood and Adolescent Immunization Schedule--United States, January-June 2004. Pediatrics 113: 142-143 [Full Version]  
  • Committee on Infectious Diseases, (2006). Recommended Childhood and Adolescent Immunization Schedule--United States, 2006. Pediatrics 117: 239-240 [Full Version]  
  • Committee on Infectious Diseases, (2000). Recommended Childhood Immunization Schedule---United States, January-December 2000. Pediatrics 105: 148-151 [Full Version]  
  • Committee on Infectious Diseases, (2006). Prevention of Pertussis Among Adolescents: Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine. Pediatrics 117: 965-978 [Abstract] [Full Version]  
  • Brenner, R. A., Simons-Morton, B. G., Bhaskar, B., Das, A., Clemens, J. D., the NIH-D.C. Initiative Immunization Working Group, (2001). Prevalence and Predictors of Immunization Among Inner-City Infants: A Birth Cohort Study. Pediatrics 108: 661-670 [Abstract] [Full Version]  
  • Fair, E., Murphy, T. V., Golaz, A., Wharton, M. (2002). Philosophic Objection to Vaccination as a Risk for Tetanus Among Children Younger Than 15 Years. Pediatrics 109: e2-2 [Abstract] [Full Version]  
  • Cherry, J. D. (2005). Pertussis Vaccines for Adolescents and Adults. Pediatrics 116: 755-756 [Full Version]  
  • Minkovitz, C. S., Strobino, D., Scharfstein, D., Hou, W., Miller, T., Mistry, K. B., Swartz, K. (2005). Maternal Depressive Symptoms and Children's Receipt of Health Care in the First 3 Years of Life. Pediatrics 115: 306-314 [Abstract] [Full Version]  
  • Piedra, P. A., Gaglani, M. J., Riggs, M., Herschler, G., Fewlass, C., Watts, M., Kozinetz, C., Hessel, C., Glezen, W. P. (2005). Live Attenuated Influenza Vaccine, Trivalent, Is Safe in Healthy Children 18 Months to 4 Years, 5 to 9 Years, and 10 to 18 Years of Age in a Community-Based, Nonrandomized, Open-Label Trial. Pediatrics 116: e397-e407 [Abstract] [Full Version]  
  • Skowronski, D. M., Remple, V. P., Macnabb, J., Pielak, K., Patrick, D. M., Halperin, S. A., Scheifele, D. (2003). Injection-Site Reactions to Booster Doses of Acellular Pertussis Vaccine: Rate, Severity, and Anticipated Impact. Pediatrics 112: e453-459 [Abstract] [Full Version]  
  • Committee on Community Health Services and Committ, (2003). Increasing Immunization Coverage. Pediatrics 112: 993-996 [Abstract] [Full Version]  
  • Taranger, J., Trollfors, B., Bergfors, E., Knutsson, N., Lagergard, T., Schneerson, R., Robbins, J. B. (2001). Immunologic and Epidemiologic Experience of Vaccination With a Monocomponent Pertussis Toxoid Vaccine. Pediatrics 108: e115-115 [Abstract] [Full Version]  
  • Saari, T. N., and Committee on Infectious Diseases, (2003). Immunization of Preterm and Low Birth Weight Infants. Pediatrics 112: 193-198 [Abstract] [Full Version]  
  • Miller, L. C., Comfort, K., Kelly, N. (2001). Immunization Status of Internationally Adopted Children. Pediatrics 108: 1050-1051 [Full Version]  
  • Robinson, M. J., Heal, C., Gardener, E., Powell, P., Sims, D. G. (2004). Immunization Responses in Preterm Infants Who Receive Postnatal Steroid Treatment: In Reply. Pediatrics 114: 1128-1129 [Full Version]  
  • Berrington, J., Fenton, A. (2004). Immunization Responses in Preterm Infants Who Receive Postnatal Steroid Treatment. Pediatrics 114: 1127-1128 [Full Version]  
  • Rosenthal, J., Rodewald, L., McCauley, M., Berman, S., Irigoyen, M., Sawyer, M., Yusuf, H., Davis, R., Kalton, G. (2004). Immunization Coverage Levels Among 19- to 35-Month-Old Children in 4 Diverse, Medically Underserved Areas of the United States. Pediatrics 113: e296-e302 [Abstract] [Full Version]  
  • Jenkins, C. N. H., McPhee, S. J., Wong, C., Nguyen, T., Euler, G. L. (2000). Hepatitis B Immunization Coverage Among Vietnamese-American Children 3 to 18 Years Old. Pediatrics 106: 78e-78 [Abstract] [Full Version]  
  • Berrington, J. E., Cant, A. J., Matthews, J. N.S., O'Keeffe, M., Spickett, G. P., Fenton, A. C. (2006). Haemophilus influenzae Type b Immunization in Infants in the United Kingdom: Effects of Diphtheria/Tetanus/Acellular Pertussis/Hib Combination Vaccine, Significant Prematurity, and a Fourth Dose. Pediatrics 117: e717-e724 [Abstract] [Full Version]  
  • Hartley, L. M., MRCP, B., Khwaja, O. S., Verity, C. M., FRCPCH, B. (2001). Glutaric Aciduria Type 1 and Nonaccidental Head Injury. Pediatrics 107: 174-175 [Full Version]  
  • Rennels, M. B., Deloria, M. A., Pichichero, M. E., Losonsky, G. A., Englund, J. A., Meade, B. D., Anderson, E. L., Steinhoff, M. C., Edwards, K. M. (2000). Extensive Swelling After Booster Doses of Acellular Pertussis-Tetanus-Diphtheria Vaccines. Pediatrics 105: e12-e12 [Abstract] [Full Version]  
  • Cohen, A. L., Veenstra, D. (2006). Economic Analysis of Prevaccination Serotesting Compared With Presumptive Immunization for Polio, Diphtheria, and Tetanus in Internationally Adopted and Immigrant Infants. Pediatrics 117: 1650-1655 [Abstract] [Full Version]  
  • DeStefano, F., Mullooly, J. P., Okoro, C. A., Chen, R. T., Marcy, S. M., Ward, J. I., Vadheim, C. M., Black, S. B., Shinefield, H. R., Davis, R. L., Bohlke, K. (2001). Childhood Vaccinations, Vaccination Timing, and Risk of Type 1 Diabetes Mellitus. Pediatrics 108: e112-112 [Abstract] [Full Version]  
  • Cherry, J. D. (2005). Cherry Picking: In Reply. Pediatrics 116: 1056-1057 [Full Version]  
  • Fleischer, D., Wood, R. A. (2003). CHILDHOOD VACCINATIONS AND RISK OF ASTHMA. Pediatrics 112: 478-479 [Full Version]  
  • Cooper, A., Yusuf, H., Rodewald, L., Malik, T., Pollard, R., Pickering, L. (2001). Attitudes, Practices, and Preferences of Pediatricians Regarding Initiation of Hepatitis B Immunization at Birth. Pediatrics 108: e98-98 [Abstract] [Full Version]  
  • Robinson, M. J, Heal, C., Gardener, E., Powell, P., Sims, D. G. (2004). Antibody Response to Diphtheria-Tetanus-Pertussis Immunization in Preterm Infants Who Receive Dexamethasone for Chronic Lung Disease. Pediatrics 113: 733-737 [Abstract] [Full Version]  
  • Pichichero, M. E., Blatter, M. M., Kennedy, W. A., Hedrick, J., Descamps, D., Friedland, L. R. (2006). Acellular Pertussis Vaccine Booster Combined With Diphtheria and Tetanus Toxoids for Adolescents. Pediatrics 117: 1084-1093 [Abstract] [Full Version]